Compugen (CGEN) EPS (Weighted Average and Diluted) (2009 - 2025)
Compugen's (CGEN) quarterly EPS (Weighted Average and Diluted) came in at -$0.07 in Q3 2025, down 164.42% year-on-year from $0.11 in Q3 2024, and up 100.0% quarter-over-quarter from -$135087.5 in Q2 2025.
Compugen (CGEN) EPS (Weighted Average and Diluted) (2009 - 2025) Analysis & Trends
Compugen has disclosed EPS (Weighted Average and Diluted) across 15 years of filings, most recently posting -$0.07 for Q3 2025.
- EPS (Weighted Average and Diluted) for Q3 2025 came in at -$0.07, down 164.42% year-over-year; the trailing twelve-month figure through Sep 2025 was -$0.07 (down 164.42% YoY), and the FY2015 annual result was -$0.4, down 53.85% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$0.07 for Q3 2025 at Compugen, up from -$135087.5 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $129836.4 in Q2 2022 to a low of -$166230.0 in Q2 2024.
- The 5-year median for EPS (Weighted Average and Diluted) is -$0.22 (2023), against an average of -$26596.6.
- Across the five-year window, EPS (Weighted Average and Diluted) surged 414.44% in 2022 and plunged 51592788.81% in 2024, its largest moves.
- Compugen's EPS (Weighted Average and Diluted) stood at -$41291.3 in 2021, then soared by 414.44% to $129836.4 in 2022, then tumbled by 100.0% to -$0.11 in 2023, then soared by 202.63% to $0.11 in 2024, then slumped by 164.42% to -$0.07 in 2025.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.07 (Q3 2025), -$135087.5 (Q2 2025), and $0.11 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 0.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -0.61 |
| 10 | Compugen | 191.48 Mn | 99.73 Mn | 352,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -0.07 |
| Jun 30, 2025 | -135,087.50 |
| Sep 30, 2024 | 0.11 |
| Jun 30, 2024 | -166,230.00 |
| Sep 30, 2023 | -0.11 |
| Jun 30, 2023 | -0.32 |
| Jun 30, 2022 | 129,836.36 |
| Jun 30, 2021 | -41,291.30 |
| Mar 31, 2019 | -0.14 |
| Mar 31, 2018 | 0.00 |
| Mar 31, 2017 | -0.17 |
| Dec 31, 2015 | -0.01 |
| Jun 30, 2015 | -0.14 |
| Dec 31, 2014 | -0.03 |
| Jun 30, 2014 | -0.07 |
| Dec 31, 2013 | -0.09 |
| Sep 30, 2013 | -0.12 |
| Jun 30, 2013 | -0.09 |
| Dec 31, 2012 | -0.15 |
| Sep 30, 2012 | -0.10 |